CA
MRVI icon

Cliff Asness’s Maravai LifeSciences MRVI Stock Holding History

Cliff Asness’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$529K Buy
84,821
+2,285
+3% +$9.87K ﹤0.01% 3367
2026
Q1 		$234K Sell
82,536
-28,595
-26% -$96.9K ﹤0.01% 3530
2025
Q4 		$361K Buy
111,131
+49,551
+80% +$167K ﹤0.01% 3084
2025
Q3 		$177K Buy
61,580
+1,740
+3% +$4.44K ﹤0.01% 3283
2025
Q2 		$144K Buy
59,840
+44,313
+285% +$93.1K ﹤0.01% 3118
2025
Q1 		$34.3K Sell
15,527
-35,835
-70% -$142K ﹤0.01% 3103
2024
Q4 		$280K Sell
51,362
-268,107
-84% -$1.73M ﹤0.01% 2516
2024
Q3 		$2.65M Sell
319,469
-453,544
-59% -$3.92M ﹤0.01% 1357
2024
Q2 		$5.53M Sell
773,013
-2,052,862
-73% -$17.7M 0.01% 975
2024
Q1 		$24.2M Sell
2,825,875
-678,236
-19% -$4.59M 0.04% 461
2023
Q4 		$23M Buy
3,504,111
+1,755,108
+100% +$11.3M 0.04% 461
2023
Q3 		$17.2M Buy
1,749,003
+779,838
+80% +$8.56M 0.04% 515
2023
Q2 		$12M Sell
969,165
-322,889
-25% -$4.36M 0.03% 613
2023
Q1 		$18M Sell
1,292,054
-168,598
-12% -$2.42M 0.04% 501
2022
Q4 		$20.8M Buy
1,460,652
+602,852
+70% +$9.49M 0.05% 465
2022
Q3 		$21.9M Buy
857,800
+264,660
+45% +$6.64M 0.05% 413
2022
Q2 		$16.1M Buy
593,140
+441,489
+291% +$14M 0.04% 550
2022
Q1 		$5.35M Buy
151,651
+146,519
+2,855% +$4.91M 0.01% 836
2021
Q4 		$215K Buy
+5,132
New +$208K ﹤0.01% 2068

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.91B AUM 14.64% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
1WCM
12 West Capital Management New York $535M AUM 25.99% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OAM
Ophir Asset Management Sydney, Australia $1.22B AUM 100.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return

Cliff Asness's MRVI Position: Q2 2026 in Review

Cliff Asness increased its Maravai LifeSciences (MRVI) stake by 2.8% in Q2 2026, buying an estimated $9.87K and bringing the position to 84,821 shares worth $529K. The position accounts for ﹤0.01% of the portfolio, ranked #3367.

Cliff Asness first reported a position in MRVI in Q4 2021 and has held it in 19 quarters since. The position peaked at $24.2M in Q1 2024. 177 funds tracked by Wall St. Rank hold MRVI as of Q2 2026.

  • Cliff Asness held 84,821 shares of Maravai LifeSciences worth $529K as of Q2 2026.
  • Cliff Asness bought 2,285 Maravai LifeSciences shares in Q2 2026, an estimated $9.87K.
  • Maravai LifeSciences made up ﹤0.01% of Cliff Asness's portfolio in Q2 2026, its #3367 holding.
  • Cliff Asness first reported a position in Maravai LifeSciences in Q4 2021 and has held it in 19 quarters since.
  • Cliff Asness's Maravai LifeSciences position peaked at $24.2M in Q1 2024.
  • 177 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2026.

Based on AQR Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.